Tasquinimod and survival in men with metastatic castration-resistant prostate cancer: Results of long-term follow-up of a randomized phase II placebo-controlled trial

被引：0
|
作者：
Armstrong, Andrew J.
Haggman, Michael
Stadler, Walter Michael
Gingrich, Jeffrey R.
Assikis, Vasily J.
Polikoff, Jonathan
Denmeade, Samuel R.
George, Daniel J.
Andreou, Cal
Clark, William R.
Sieber, Paul
Agajanian, Richy
Belkoff, Laurence
Damber, Jan-Erik
Nordle, Orjan
Forsberg, Goran
Carducci, Michael Anthony
Pili, Roberto
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Uppsala Univ, Uppsala, Sweden
[3] Univ Chicago, Chicago, IL 60637 USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Peachtree Hematol Oncol Consultants, Atlanta, GA USA
[6] Natl Surg Breast & Bowel Project, San Diego, CA USA
[7] Kaiser Permanente Southern Calif, San Diego, CA USA
[8] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[9] Andreou Res, Surrey, BC, Canada
[10] Alaska Clin Res Ctr, Anchorage, AK USA
[11] Urol Associates Lancaster Ltd, Lancaster, PA USA
[12] Agajanian Inst Onc & Hem, Whittier, CA USA
[13] Urol Consultants SE PA, Bala Cynwyd, PA USA
[14] Urologmottagningen, Gothenburg, Sweden
[15] Act Biotech, Lund, Sweden
[16] Johns Hopkins Univ Sch Med, Baltimore, MD USA
[17] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[18] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4550
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
    Armstrong, Andrew J.
    Kaboteh, Reza
    Carducci, Michael A.
    Damber, Jan-Erik
    Stadler, Walter M.
    Hansen, Mats
    Edenbrandt, Lars
    Forsberg, Goran
    Nord, Orjan
    Pili, Roberto
    Morris, Michael J.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1308 - 1316
  • [2] Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
    Sternberg, Cora
    Armstrong, Andrew
    Pili, Roberto
    Ng, Siobhan
    Huddart, Robert
    Agarwal, Neeraj
    Khvorostenko, Denis
    Lyulko, Olexiy
    Brize, Arija
    Vogelzang, Nicholas
    Delva, Remy
    Harza, Mihai
    Thanos, Anastasios
    James, Nicholas
    Werbrouck, Patrick
    Boegemann, Martin
    Hutson, Thomas
    Milecki, Piotr
    Chowdhury, Simon
    Gallardo, Enrique
    Schwartsmann, Gilberto
    Pouget, Jean-Christophe
    Baton, Frederique
    Nederman, Thore
    Tuvesson, Helen
    Carducci, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (22) : 2636 - U136
  • [3] Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
    Chamorey, Emmanuel
    Pujalte-Martin, Marc
    Ferrero, Jean-Marc
    Mahammedi, Hakim
    Gravis, Gwenaelle
    Roubaud, Guilhem
    Beuzeboc, Philippe
    Largillier, Remy
    Borchiellini, Delphine
    Linassier, Claude
    Bouges, Helene
    Etienne-Grimaldi, Marie-Christine
    Schiappa, Renaud
    Gal, Jocelyn
    Milano, Gerard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [4] A Phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castration-resistant prostate cancer (mCRPC), secondary endpoints.
    Sternberg, Cora N.
    Armstrong, Andrew J.
    Pili, Roberto
    Nederman, Tore
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial
    Paller, Channing J.
    Zahurak, Marianna L.
    Mandl, Adel
    Metri, Nicole A.
    Lalji, Aliya
    Heath, Elisabeth
    Kelly, William K.
    Hoimes, Christopher
    Barata, Pedro
    Taksey, Jason
    Garrison, Dominique A.
    Patra, Kartick
    Milne, Ginger L.
    Anders, Nicole M.
    Nauroth, Julie M.
    Durham, Jennifer N.
    Marshall, Catherine H.
    Markowski, Mark C.
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    Carducci, Michael A.
    Denmeade, Samuel R.
    Levine, Mark
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 2174 - 2182
  • [6] Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer A meta-analysis of randomized controlled trials
    Gong, Ping
    Liu, Hongjian
    Liu, Xinyu
    Zhou, Ge
    Liu, Meitian
    Yang, Xiaodi
    Xiong, Wenjing
    Wang, Qi
    Ma, Juan
    Ren, Zheng
    He, Minfu
    Zhang, Xiumin
    [J]. MEDICINE, 2018, 97 (46)
  • [7] A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer
    Armstrong, Andrew J.
    Shen, Tong
    Halabi, Susan
    Kemeny, Gabor
    Bitting, Rhonda Lynn
    Kartcheske, Patricia
    Embree, Elizabeth
    Morris, Karla
    Winters, Carolyn
    Jaffe, Tracy
    Fleming, Mark T.
    George, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [8] A Phase II Trial of Temsirolimus in Men With Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Shen, Tong
    Halabi, Susan
    Kemeny, Gabor
    Bitting, Rhonda L.
    Kartcheske, Patricia
    Embree, Elizabeth
    Morris, Karla
    Winters, Carolyn
    Jaffe, Tracy
    Fleming, Mark
    George, Daniel J.
    [J]. CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 397 - 406
  • [9] Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
    Smith, Matthew R.
    Saad, Fred
    Coleman, Robert
    Shore, Neal
    Fizazi, Karim
    Tombal, Bertrand
    Miller, Kurt
    Sieber, Paul
    Karsh, Lawrence
    Damiao, Ronaldo
    Tammela, Teuvo L.
    Egerdie, Blair
    Van Poppel, Hendrik
    Chin, Joseph
    Morote, Juan
    Gomez-Veiga, Francisco
    Borkowski, Tomasz
    Ye, Zhishen
    Kupic, Amy
    Dansey, Roger
    Goessl, Carsten
    [J]. LANCET, 2012, 379 (9810): : 39 - 46
  • [10] Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)
    Crabb, Simon J.
    Griffiths, Gareth
    Marwood, Ellice
    Dunkley, Denise
    Downs, Nichola
    Martin, Karen
    Light, Michelle
    Northey, Josh
    Wilding, Sam
    Whitehead, Amy
    Shaw, Emily
    Birtle, Alison J.
    Bahl, Amit
    Elliott, Tony
    Westbury, Charlotte
    Sundar, Santhanam
    Robinson, Angus
    Jagdev, Satinder
    Kumar, Satish
    Rooney, Claire
    Salinas-Souza, Carolina
    Stephens, Christine
    Khoo, Vincent
    Jones, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) : 190 - +
12345